Profile
Luc Tanguay served as the President, CEO & Non-Independent Director of Theratechnologies, Inc. from 2012 to 2020.
Prior to that, he was a Director at Ambrilia Biopharma, Inc. from 2006 to 2010.
He also served as the Chairman of Valeo Management LP.
Tanguay received his undergraduate and graduate degrees from the University of Sherbrooke.
Former positions of Luc Tanguay
Companies | Position | End |
---|---|---|
THERATECHNOLOGIES INC. | Chief Executive Officer | 06/04/2020 |
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Director/Board Member | 31/03/2010 |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Chairman | - |
Training of Luc Tanguay
University of Sherbrooke | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
THERATECHNOLOGIES INC. | Health Technology |
Private companies | 2 |
---|---|
Ambrilia Biopharma, Inc.
Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Health Technology |
Valeo Management LP
Valeo Management LP Miscellaneous Commercial ServicesCommercial Services Valeo Management LP offers research commercialization services. The firm provides Life sciences and biotechnologies, engineering, information and communications technologies services. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
- Stock Market
- Insiders
- Luc Tanguay